Impact BioMedical’s Proprietary Equivir Compound to Treat Viral Infection Receives Clean Patentability Report from World Intellectual Property Organization’s ISA Division
March 03, 2022 08:00 ET
|
DSS, Inc.
ROCHESTER, N.Y., March 03, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE American: DSS), along with its scientific research partner Global Research...
CORRECTION - DSS Announces Letter to Shareholders
February 28, 2022 17:15 ET
|
DSS, Inc.
ROCHESTER, N.Y., Feb. 28, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by DSS, Inc. (NYSE American: DSS), please note that in paragraph fourteen, [With more...
DSS Announces Letter to Shareholders
February 28, 2022 08:00 ET
|
DSS, Inc.
ROCHESTER, N.Y., Feb. 28, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with ten operating business lines in diverse, high-growth...
DSS to Present at Aegis Virtual Conference
February 22, 2022 17:00 ET
|
DSS, Inc.
ROCHESTER, N.Y., Feb. 22, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth...
DSS Receives $17 Million Investment from Alset EHome International
January 25, 2022 16:30 ET
|
DSS, Inc.
ROCHESTER, N.Y., Jan. 25, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth...
DSS Acquires 25.1% of Alset International Limited
January 19, 2022 12:13 ET
|
DSS, Inc.
DSS adds True Partner Capital with $1.7B AUM into DSS Securities; greatly enhancing the portfolio of the finance and asset management division of DSS ROCHESTER, N.Y., Jan. 19, 2022 (GLOBE NEWSWIRE)...
DSS Expands American Medical REIT Subsidiary with Acquisition of 21,900 Sq. Ft. Medical Office Building
January 12, 2022 08:30 ET
|
DSS, Inc.
ROCHESTER, N.Y., Jan. 12, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth...
Impact BioMedical Announces New Bioplastics Test Results
January 11, 2022 10:00 ET
|
DSS, Inc.
ROCHESTER, N.Y., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc., a wholly owned subsidiary of DSS, Inc. (NYSE American: DSS) along with its scientific research partner Global Research and...
DSS Retains Leading Blockchain and Digital Assets Law Firm to Accelerate Launch of Digital Asset Exchange
January 10, 2022 08:30 ET
|
DSS, Inc.
ROCHESTER, N.Y., Jan. 10, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth...
DSS Provides Update on Expansion of Premier Packaging Subsidiary
December 22, 2021 07:30 ET
|
DSS, Inc.
ROCHESTER, N.Y., Dec. 22, 2021 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company with nine operating business lines in diverse, high-growth...